Nutritional supplements and extracts like Bael have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Bael supplement and why should not take them?
Is it okay to take Bael extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.
A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.
To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.
Taking Bael extracts or nutritional supplements may benefit Primary Uterine Undifferentiated Carcinoma patients on Carboplatin treatment over Cleaver nutritional supplements. But Bael supplements or Bael extracts offer less benefit if on Cyclophosphamide treatment for Primary Myeloproliferative Neoplasms compared to Costus. Similarly, taking nutritional supplements Bael may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene NF1 over Blueberry. But avoid nutritional supplements Bael when at genetic risk of cancer due to mutation of gene JAK2.
The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Bael beneficial and should not be taken? Why should Bael be not taken? Who should not take Bael? What are side effects of Bael with Cyclophosphamide chemotherapy? What are the benefits of Bael for cancer? Can Bael help fight cancer and so on.
Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.
Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.
These are some example questions which nutrition planning should help answer for you. Should you take supplements Bael? Should you take it when at genetic risk of cancer for mutation of gene NF1? Should you take it when at genetic risk of cancer for mutation of gene JAK2? Should you take it when diagnosed with Primary Myeloproliferative Neoplasms? Should you take it when diagnosed with Primary Uterine Undifferentiated Carcinoma? Should you take it when on Carboplatin treatment? Should you continue taking it if you change your treatment from Carboplatin to Cyclophosphamide? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Bael extracts and nutritional supplements.
Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Uterine Undifferentiated Carcinoma or Primary Myeloproliferative Neoplasms, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Bael.
So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Bael extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene NF1 the same as due to mutation of gene JAK2? Are the implications of Primary Uterine Undifferentiated Carcinoma the same as Primary Myeloproliferative Neoplasms? Is it one and the same if you are on treatment with Cyclophosphamide or Carboplatin?
Bael – An Extract or Nutritional Supplement
Bael is a plant native to India, Nepal, Malaysia, Thailand, Sri Lanka and Southeast Asian countries. It is also known as Bengal quince, Aegle marmelos, Golden apple, Wood apple, Stone apple and Japanese bitter orange. The raw fruit, root, leaf, and branch of Bael are considered to have medicinal value with antioxidant, anti-inflammatory and antimicrobial properties. Following are some of the purported uses/benefits of Bael:
- May be used for constipation and diarrhea
- May help maintaining blood sugar levels
- May help fight skin infections
- May help reduce cholesterol
- May help reduce ulcers
Bael supplements contain many active ingredients including Palmitic Acid, Linolenic Acid, Linoleic Acid, Citric Acid and Auraptene at different concentration levels. The molecular pathways which are regulated by Bael include WNT Beta Catenin Signaling, Growth Factor Signaling, Chemokine Signaling and Oncogenic Cancer Epigenetics. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Bael individually or in combination is an important decision to be made. When making decisions on the use of supplement Bael over other nutritional supplements – do consider all these factors.
Who Should not take Bael Supplements and Why?
There is no easy way to answer the question “For which cancers should I not chooseBael nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Bael in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Bael should be avoided or not and why.
1. Will Bael Supplements benefit Primary Myeloproliferative Neoplasms patients undergoing Cyclophosphamide treatment?
Primary Myeloproliferative Neoplasms is characterized and driven by specific genetic mutations like JAK2, CALR and TET2 leading to biochemical pathway changes in Growth Factor Signaling, AGE-RAGE Signaling, Chemokine Signaling, Antigen Presentation, Post Translation Modification and Oncogenic Cancer Epigenetics. A cancer treatment like Cyclophosphamide works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Bael supplement should not be taken for Primary Myeloproliferative Neoplasms along with treatment Cyclophosphamide. Bael supplement impacts the biochemical pathway called Growth Factor Signaling which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any
2. Will Bael Supplements benefit Primary Uterine Undifferentiated Carcinoma Patients undergoing Carboplatin Treatment?
Primary Uterine Undifferentiated Carcinoma is characterized and driven by specific genetic mutations like KMT2C, TP53 and NSD1 leading to biochemical pathway changes in WNT Beta Catenin Signaling, Oncogenic Histone Methylation, Amino Acid Metabolism, Cell Cycle Checkpoints, Apoptosis and Chromatin Remodeling. A cancer treatment like Carboplatin works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Bael supplements should be considered for Primary Uterine Undifferentiated Carcinoma along with the treatment Carboplatin. Bael supplement impacts pathways/processes like WNT Beta Catenin Signaling which either obstruct drivers of Primary Uterine Undifferentiated Carcinoma and/or improve Carboplatin treatment effect.
Foods to Eat After Cancer Diagnosis!
No two cancers are the same. Go beyond the common nutrition guidelines for everyone and make personalized decisions about food and supplements with confidence.
3. What about Bael Supplements for Healthy Individuals with JAK2 Mutation associated Genetic Risk?
Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. JAK2 is one of the genes generally available in panels for cancer risk testing.
JAK2 mutation causes biochemical pathways/processes like Chemokine Signaling, Cytokine Signaling, JAK-STAT Signaling and Immune Checkpoints to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Bael should not be taken when the genetic panel identifies mutation of JAK2 for Myeloproliferative Neoplasms. Bael impacts pathways/processes like Chemokine Signaling and creates adverse conditions with JAK2.
4. What about Bael Supplements for Healthy Individuals with NF1 Mutation associated Genetic Risk?
NF1 is one of the genes available in panels for cancer risk testing. NF1 mutation causes biochemical pathways/processes like Oncogenic Cancer Epigenetics and RAS-RAF Signaling to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Bael supplements may be considered when the genetic panel identifies mutations in NF1 for Pheochromocytoma And Paraganglioma. Bael impacts pathways/processes like Oncogenic Cancer Epigenetics and creates a canceling effect in those individuals with NF1 mutation.
* Other Factors are also included like BMI, Treatments, Lifestyle Habits
It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Bael are chosen by you and can influence outcomes.
“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.
The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.
What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.
The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.
Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.
- Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.
- Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
- Auraptene suppresses inflammatory responses in activated RAW264 macrophages by inhibiting p38 mitogen-activated protein kinase activation.
- A review of the pharmacological and therapeutic effects of auraptene.
- Role of phospholipase D in migration and invasion induced by linoleic acid in breast cancer cells.
- cBioPortal for Cancer Genomics
- An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.
- cBioPortal for Cancer Genomics
- Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
- Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.
Personalized Nutrition for Cancer!
Cancer changes with time. Customize and modify your nutrition based on cancer indication, treatments, lifestyle, food preferences, allergies and other factors.